Skip to main content

TomEnterprise AB's Form 4 filing

DiaMedica Therapeutics Inc. (DMAC) · filed Jul 1, 2024

Accession no.
0001104659-24-076844
Filed
Jul 1, 2024, 4:27 PM ET
Trade date
Jun 28, 2024
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $3.00M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
TomEnterprise ABCIK 000188743510% Owner
Von Koch ThomasCIK 000193891510% Owner
TomEnterprise Private ABCIK 000195678210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 28, 2024Common SharesPPurchaseAcquired+1,200,000$2.50+$3,000,0005,526,435Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)